bDFS (%)
Ref. (with actuarial data)
No. patients
Median follow-up in months (range)
Technique
PSA threshold
Low risk
Intermediate risk
High risk
nADT (%)
Bahn et al. [37] (7-year data)
590
68 (NA)
LN/Ar
<0.5
<1.0
61
87
68
79
61
71
91
Cohen et al. [39] (10-year data)
204
12.6 (9.7–15.0)
LN
ASTRO
56 (all risk groups)
0
Han et al. [38] (1-year data)
122
12 (NA)
Ar
<0.4
78
NA
71
37
Jones et al. [36]
(5-year data)
1198
24 (SD ± 26)
LN/Ar
ASTRO
85
73
75
NA
Long et al. [35] (5-year data)
975
24 (SD ± 16.5)
LN/Ar
<0.5
<1.0
60
76
61
71
36
45
33
Table 17.2
Results of salvage cryosurgery
bDFS (%) | ||||||||
---|---|---|---|---|---|---|---|---|
Ref. (with actuarial data) | No. patients | Median follow-up in months (range) | Technique | PSA threshold | Low risk | Intermediate risk | High risk | nADT (%) |
Bahn et al. [43] (7-year data) | 59 | 82 (NA) | Ar | <0.5 | 59 (all | NA | ||
Chin et al. [40] (5-year data) | 118 | 19 (3–54) | Ar | <0.5 | NA | NA | 34 | 60 |
Ismail et al. [41] (5-year data) | 100 | 33 (mean)(12–79) | Ar | <0.5 | 73 | 45 | 11 | 46 |
Ng et al. [42] (8-year data) | 187 | 39 (mean) (NA) | Ar | Houston | 56 | NA | 14 | 71 |
Pisters et al. [14] (5-year data) | 279 | 22 (SD ± 25) | LN/Ar | ASTRO Phoenix | 59 (all risk groups) 55 (all risk groups) | NA |
The major complications that were frequently reported in the early periods of cryosurgery for prostate cancer in the 1960s through the 1980s have been significantly reduced in both the primary and salvage settings. The contemporary reports for primary cryoablation reveal complication rates of <0.5% for rectal fistula formation [44], <8% for permanent urinary incontinence [45] and <15% for urethral sloughing when a urethral warming device is employed [46]. Erectile dysfunction remains a significant problem in patients undergoing total gland ablation in men in which the ice ball is allowed to extend to both neurovascular bundles. One year and four year potency rates of 41.4 and 51.3% have been reported with penile rehabilitation [47]. In the salvage setting complications are higher with incontinence reported in approximately 10%, urethral sloughing in 10%, rectal pain in 17% and rectal fistula in 3%. Tables 17.3 and 17.4, show the reported complications in selected series of patients undergoing primary and salvage therapy, respectively [14, 31, 35–42, 48–50].
Table 17.3
Complications (%) after primary cryosurgery
Ref. | No. patients | Technique | Fistula | Retention | Incontinence | Impotence | Perineal pain |
---|---|---|---|---|---|---|---|
Badalament et al. [49] | 290 | Cryocare | 0.4 | NA | 4.3 | 85 | 12 |
Bahn et al. [37] | 590 | LN/Ar | 0.004 | 5.5 | 4.3 | 95 | NA |
Cohen et al. [39] | 239 | Cryocare Seednet | 2.2 | 3 | 0.4 | 4 | 0.4 |
Han et al. [38] | 122 | AR | 0 | NA | 3 | 87 | 6 |
Jones et al. [36] | 1198 | LN/Ar | 0.4 | NA | 2.9 | 91 | NA |
Long et al. [35] | 975 | LN/Ar | 0.4 | 10 | 7.5 | 93 | NA |
Shinohara et al. [31] | 102 | NA | 1 | 23 | 15 | 86 | 3 |
Wake et al. [48] | 106 | Cryocare | 0 | 22 | 8 | NA | NA |
Table 17.4
Complications (%) afte r salvage cryosurgery
Ref. | No. patients | Technique | Fistula | Retention | Incontience | Impotence | Perineal pain |
---|---|---|---|---|---|---|---|
Chin et al. [40] | 118 | Ar | 3.3 | 8.5 | 6.7 | NA | NA |
Ismail et al. [41] | 100 | Ar | 1 | 2 | 13 | 86 | 4 |
Katz et al.[50] | 157 | Cryocare seednet | 0 | 5.8/1.9 | 9.7 | NA | 12.8 |
Ng et al. [42] | 187 | Ar | 2 | 21 | 3 | NA | 14 |
Pisters et al. [14] | 279 | LN/Ar | 1.2 | NA | 4.4 | NA | NA |